Page 3 - Onward Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Onward therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Onward Therapeutics Today - Breaking & Trending Today

Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy

Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy
News provided by
Share this article
Share this article
LAUSANNE, Switzerland, Feb. 17, 2021 /PRNewswire/ Onward Therapeutics SA (Onward) announced today the execution of a strategic investment in EMERCell SAS, Montpellier, France, a company that has developed a platform technology to produce off-the-shelf natural killer (NK) cells. The undisclosed amounts of the equity investment in three instalments, allow Onward to become the majority shareholder. Dr. Alain Herrera, Chief Medical Officer of Onward, has been elected Chairperson of the Board of EMERCell.
In the era of cancer immunotherapy, NK cells are one of the immune cells that can be harnessed, along with antibodies or genetic modifications to kill tumor cells. One major advantage of EMERCell s technology is its versatility in offering allogeneic, instead of autologous treatment by CAR-T or CAR-NK c ....

T Ai Pei , France General , Switzerland General , Patrick Henno , Alain Herrera , Biomunex Pharmaceuticals , Chief Medical Officer , Onward Therapeutics , Onward Therapeutics Sa , Health Care Amp Hospitals , Banking Amp Financial Services , Medical Pharmaceuticals , Venture Capital , டி ஐ பேய் , பிரான்ஸ் ஜநரல் , சுவிட்சர்லாந்து ஜநரல் , அலன் ஹெர்ரெரா , தலைமை மருத்துவ அதிகாரி , தொடர்ந்து சிகிச்சை , தொடர்ந்து சிகிச்சை ச , ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் , வங்கி ஆம்ப் நிதி சேவைகள் , மருத்துவ மருந்துகள் , துணிகர மூலதனம் ,

Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy

Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

T Ai Pei , France General , Switzerland General , Patrick Henno , Alain Herrera , Biomunex Pharmaceuticals , Chief Medical Officer , Onward Therapeutics , டி ஐ பேய் , அலன் ஹெர்ரெரா , தலைமை மருத்துவ அதிகாரி , தொடர்ந்து சிகிச்சை ,

Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology

LAUSANNE, Switzerland, Feb. 16, 2021 /PR Newswire/ Onward Therapeutics SA announced today the execution of a worldwide exclusive license and co-development agreement with Biomunex. ....

United States , France General , Switzerland General , T Ai Pei , United Kingdom , Pierre Emmanuel Gerard , Biomunex Pharmaceuticals , Onward Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , சுவிட்சர்லாந்து ஜநரல் , டி ஐ பேய் , ஒன்றுபட்டது கிஂக்டம் , பியர் இம்மானுவேல் ஜெரார்ட் , தொடர்ந்து சிகிச்சை ,